Immunogenicity and safety of a tetravalent dengue vaccine during a five-year follow-up period
In conclusion, TDV appears to have good safety and persistence of antibodies over five years.
Source: Trials in Vaccinology - Category: Infectious Diseases Source Type: research
More News: Dengue Fever | Infectious Diseases | Laboratory Medicine | Study | Typhoid | Typhoid Vaccine | Vaccines | Virology